<p>(<b>A</b>) Structure of Embelin (<b>B</b>) Cells were treated with embelin for 48h and following the termination of incubation, cell viability was measured by sulphorhodamine B assay and IC<sub>50</sub> values were calculated as mentioned in the “Materials and Methods” section. Data shown are mean ± SD of three separate experiments. * indicates p<0.01as compared with controls.</p
Background & objectives: Cancer is one of the leading causes of morbidity and mortality worldwide. L...
<p>(A) Cells were incubated for the indicated time periods with embelin (30 μM), and were stained wi...
<p>(<b>A</b>) A549 cells were treated with 15 µM embelin for different time intervals. Following the...
<p>(A and B), Pancreatic cancer AsPC-1, PANC-1, MIA PaCa-2 and Hs 766T cell lines were treated with ...
<p>(A) Cell proliferation was measured by MTT and cell number measured by absorbance at 540 nm (Abs ...
<p>(A) Mz-ChA-1 cells were treated with embelin for 24 hours and caspase 3/7 activity measured bioch...
<p>Embelin inhibits the cell viability of leukemic cells. K562 <b>(A)</b> and U937 <b>(B)</b> cells ...
<p>(A), Pancreatic cancer cell were isolated from 10-months old Kras<sup>G12D</sup> mice. Cells were...
<p>(<b>A</b>) Morphology of control and treated breast cancer cells indicative of growth arrest phen...
<p>K562 <b>(A)</b> and U937 <b>(B)</b> cells were treated either with 5 μM embelin or 5 μM LY294002 ...
<p>(A), Expression of PCNA, Ki67, caspase-3, and PARP in tumor tissues. Immunohistochemistry was per...
<p>Embelin-induced activation of caspase 8 and Bid in leukemic cell lines. K562 <b>(A)</b> and U937 ...
<p>(A) Cells were treated with 30 μM embelin for the indicated time periods, and whole cell lysates ...
<p>(A), (C), (E) Translocation of pro-apoptotic protein (Bax), cytochrome <i>c</i>, AIF, and level o...
<p>(A) KMCH cells were treated for 24 hours with TRAIL at the indicated concentrations with or witho...
Background & objectives: Cancer is one of the leading causes of morbidity and mortality worldwide. L...
<p>(A) Cells were incubated for the indicated time periods with embelin (30 μM), and were stained wi...
<p>(<b>A</b>) A549 cells were treated with 15 µM embelin for different time intervals. Following the...
<p>(A and B), Pancreatic cancer AsPC-1, PANC-1, MIA PaCa-2 and Hs 766T cell lines were treated with ...
<p>(A) Cell proliferation was measured by MTT and cell number measured by absorbance at 540 nm (Abs ...
<p>(A) Mz-ChA-1 cells were treated with embelin for 24 hours and caspase 3/7 activity measured bioch...
<p>Embelin inhibits the cell viability of leukemic cells. K562 <b>(A)</b> and U937 <b>(B)</b> cells ...
<p>(A), Pancreatic cancer cell were isolated from 10-months old Kras<sup>G12D</sup> mice. Cells were...
<p>(<b>A</b>) Morphology of control and treated breast cancer cells indicative of growth arrest phen...
<p>K562 <b>(A)</b> and U937 <b>(B)</b> cells were treated either with 5 μM embelin or 5 μM LY294002 ...
<p>(A), Expression of PCNA, Ki67, caspase-3, and PARP in tumor tissues. Immunohistochemistry was per...
<p>Embelin-induced activation of caspase 8 and Bid in leukemic cell lines. K562 <b>(A)</b> and U937 ...
<p>(A) Cells were treated with 30 μM embelin for the indicated time periods, and whole cell lysates ...
<p>(A), (C), (E) Translocation of pro-apoptotic protein (Bax), cytochrome <i>c</i>, AIF, and level o...
<p>(A) KMCH cells were treated for 24 hours with TRAIL at the indicated concentrations with or witho...
Background & objectives: Cancer is one of the leading causes of morbidity and mortality worldwide. L...
<p>(A) Cells were incubated for the indicated time periods with embelin (30 μM), and were stained wi...
<p>(<b>A</b>) A549 cells were treated with 15 µM embelin for different time intervals. Following the...